<2-Oxo-butyl>-malonsaeure-diethylester | 1907-97-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 酮酸及其衍生物
• 英文名称: <2-Oxo-butyl>-malonsaeure-diethylester
• 英文别名: <2-Oxo-butyl>-malonester；(2-Oxo-butyl)-malonester；Diethyl 2-(2-oxobutyl)propanedioate
• CAS: 1907-97-7
• 化学式: C₁₁H₁₈O₅
• 分子量: 230.261
• InChiKey: VAQFMBQWQCOPRK-UHFFFAOYSA-N

物化性质

• 沸点：
  116-117 °C(Press: 2 Torr)
• 密度：
  1.0753 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  16
• 可旋转键数：
  9
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.73
• 拓扑面积：
  69.7
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  <2-Oxo-butyl>-malonsaeure-diethylester 在 氢氧化钾 作用下， 生成 4-氧代己酸
  参考文献：
  名称：

  Temnikova,T.I.; Semenova,S.N., Journal of general chemistry of the USSR, 1965, vol. 35, # 1, p. 25 - 28

  摘要：

  DOI：
• 作为产物：
  描述：

  Diethyl 2-[(3-methyloxiran-2-yl)methyl]propanedioate 在 tin(IV) triflimidate 作用下， 以 硝基甲烷 为溶剂， 反应 3.0h， 生成 丁酰丙二酸二乙酯 、 <2-Oxo-butyl>-malonsaeure-diethylester
  参考文献：
  名称：

  Tin(IV) triflimidate-catalyzed cyclization of epoxy esters to functionalized δ-hydroxy-γ-lactones

  摘要：

  In the presence of 5 mol % of tin(IV) triflimidate, a cyclization reaction of epoxyesters to delta-hydroxy-gamma-lactones proceeding in 46-98% yields without additives, ligands, or co-catalysts was observed. The cyclization to five-membered rings is greatly favored compared to the possible six-membered rings formation and is probably under the control of a Thorpe-Ingold type effect. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tetlet.2009.03.055

文献信息

• FACTOR XIA-INHIBITING PYRIDOBENZAZEPINE AND PYRIDOBENZAZOCINE DERIVATIVES
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20170275282A1

  公开（公告）日：2017-09-28

  The invention relates to substituted pyridobenzazepine and pyridobenzazocine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

  这项发明涉及取代的吡啶苯并脑和吡啶苯并哌啶衍生物，以及其制备方法，还涉及将其用于生产用于治疗和/或预防疾病的药物，特别是心血管疾病，最好是血栓性或血栓栓塞性疾病，水肿，以及眼科疾病。
• [EN] SUBSTITUTED OXOPYRIDINE DERIVATIVES<br/>[FR] DÉRIVÉS D'OXOPYRIDINE SUBSTITUÉS
  申请人：BAYER AG

  公开号：WO2020127508A1

  公开（公告）日：2020-06-25

  The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular vascular disorders, preferably thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complications.

  这项发明涉及替代氧吡啶衍生物及其制备方法，以及它们用于制备治疗和/或预防疾病的药物，特别是血管疾病，最好是血栓性或血栓栓塞性疾病和/或血栓性或血栓栓塞性并发症。
• Factor xia-inhibiting pyridobenzazepine and pyridobenzazocine derivatives
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US10138236B2

  公开（公告）日：2018-11-27

  The invention relates to substituted pyridobenzazepine and pyridobenzazocine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

  本发明涉及取代的吡啶并氮杂卓和吡啶并氮杂卓辛衍生物及其制备工艺，还涉及用其生产治疗和/或预防疾病的药物，特别是心血管疾病，最好是血栓或血栓栓塞性疾病，水肿，以及眼科疾病。
• Malonate anion induced Favorskii-type rearrangements. 2. Reaction of acyclic .alpha.-haloketones with carbanions leading to cyclopropanols
  作者：Takashi Sakai、Tsuyoshi Katayama、Akira Takeda

  DOI：10.1021/jo00327a017

  日期：1981.7
• SAKAI TAKASHI; KATAYAMA TSUYOSHI; TAKEDA AKIRA, J. ORG. CHEM., 1981, 46, NO 14, 2924-2931
  作者：SAKAI TAKASHI、 KATAYAMA TSUYOSHI、 TAKEDA AKIRA

  DOI：——

  日期：——